Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Operating Margin (2016 - 2025)

Historic Operating Margin for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to 21.01%.

  • Bristol Myers Squibb's Operating Margin rose 165600.0% to 21.01% in Q4 2025 from the same period last year, while for Dec 2025 it was 9.56%, marking a year-over-year increase of 367000.0%. This contributed to the annual value of 9.56% for FY2025, which is 367100.0% up from last year.
  • Per Bristol Myers Squibb's latest filing, its Operating Margin stood at 21.01% for Q4 2025, which was up 165600.0% from 2.63% recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Operating Margin ranged from a high of 1.8% in Q1 2023 and a low of 121.77% during Q1 2024
  • In the last 5 years, Bristol Myers Squibb's Operating Margin had a median value of 6.58% in 2022 and averaged 14.01%.
  • Its Operating Margin has fluctuated over the past 5 years, first tumbled by -1235700bps in 2024, then skyrocketed by 1212200bps in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Operating Margin (Quarter) stood at 4.16% in 2021, then plummeted by -55bps to 6.44% in 2022, then tumbled by -45bps to 9.33% in 2023, then crashed by -303bps to 37.57% in 2024, then skyrocketed by 44bps to 21.01% in 2025.
  • Its Operating Margin stands at 21.01% for Q4 2025, versus 2.63% for Q3 2025 and 13.03% for Q2 2025.